Software developer Voxar has agreed to license several PointDx patents related to virtual endoscopy. This is the second such deal in recent months. The last assigned licenses to Siemens regarding virtual endoscopy patents held by PointDx (SCAN 10/9/03).
Software developer Voxar has agreed to license several PointDx patents related to virtual endoscopy. This is the second such deal in recent months. The last assigned licenses to Siemens regarding virtual endoscopy patents held by PointDx (SCAN 10/9/03).
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.